Roche secures FDA approval, CLIA waiver for cobas liat STI test
The cobas liat STI panels include tests for chlamydia and gonorrhea (CT/NG) and chlamydia, gonorrhea, and Mycoplasma genitalium (CT/NG/MG), which run on Roche’s cobas liat system
Abbott Laboratories’ Q4 2024 net income increases to $9.23bn
Inflammatix secures FDA approval for TriVerity test system
Clarius unveils new advancements in ultrasound software
Aptyx acquires Medical Murray’s Charlotte facility to expand interventional products expertise
CapsoVision’s CapsoCam Plus receives FDA clearance for remote ingestion
Analysis
View More
Risks
View MoreNavigating the impact of interstate armed conflict on the medical device development industry
By understanding and preparing for the potential impacts of geopolitical instability, medical device companies can enhance their resilience and continue to deliver critical healthcare solutions in an increasingly complex global...
More Risks
White Papers
View More
Societal polarisation and its impact on the medical device development industry
Addressing the challenges posed by extreme weather events in the medical device development industry
Economic downturn: challenges and opportunities in the medical device development industry
Biodiversity loss and ecosystem collapse: the impact on the medical device development industry